HLA-B*5701 ASSAY POSITIVE

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting HLA-B*5701 ASSAY POSITIVE:

# Drug Count
0 ABACAVIR 2
1 ABACAVIR SULFATE 2
2 CABOTEGRAVIR SODIUM 2
3 RILPIVIRINE 2
4 SERTRALINE 2
5 ATAZANAVIR 1
6 CABOTEGRAVIR 1
7 EMTRICITABINE 1
8 FLUCONAZOLE 1
9 RITONAVIR 1
See all common drugs associated with HLA-B*5701 ASSAY POSITIVE

HLA-B*5701 ASSAY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CABOTEGRAVIR SODIUM 2 0.0012
1 RILPIVIRINE 2 0.0003
2 ABACAVIR SULFATE 2 0.0002
3 CABOTEGRAVIR 1 0.0001
4 ATAZANAVIR 1 0.0001
5 RITONAVIR 100 MG 1 0.0001
6 FLUCONAZOLE 1 0.0000
See all drugs enriched for association with HLA-B*5701 ASSAY POSITIVE

HLA-B*5701 ASSAY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Protease Inhibitor [EPC] 1 0.0000
1 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
2 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
3 Azole Antifungal [EPC] 1 0.0000
See all drug classes enriched for association with HLA-B*5701 ASSAY POSITIVE